USD 13.2
(-2.58%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | -375.29 Million | 916.7 Million |
Net Income | - | - | - | - | -334.87 Million | 430.37 Million |
Depreciation & Amortization | - | - | - | - | 158.4 Million | 117.27 Million |
Deferred income taxes | - | - | - | - | -58.76 Million | -5.42 Million |
Stock-based compensation | - | - | - | - | 26.58 Million | 23.28 Million |
Change in working capital | - | - | - | - | -161.1 Million | 399.97 Million |
Other non-cash items | - | - | - | - | -64.3 Million | -54.19 Million |
Investing Cash Flow | - | - | - | - | 633.71 Million | -1.6 Billion |
Investments in PPE | - | - | - | - | -199.4 Million | -117.04 Million |
Acquisitions | - | - | - | - | 165.42 Million | -402.23 Million |
Investment purchases | - | - | - | - | -3.2 Billion | -2.83 Billion |
Sales/Maturities of investments | - | - | - | - | 3.27 Billion | 1.94 Billion |
Other Investing Activities | - | - | - | - | 589.77 Million | -202.69 Million |
Financing Cash Flow | - | - | - | - | -57.85 Million | 268.37 Million |
Debt repayment | - | - | - | - | -63.4 Million | -7.19 Million |
Dividends payments | - | - | - | - | -190.98 Million | -156.07 Million |
Common Stock Repurchased | - | - | - | - | -52.85 Million | -152.39 Million |
Common Stock Issuance | - | - | - | - | 298.74 Million | 346 Thousand |
Other Financing Activities | - | - | - | - | -102.21 Million | 583.69 Million |
Accounts receivables | - | - | - | - | -1.66 Billion | -965.29 Million |
Accounts payables | - | - | - | - | 48.68 Million | 95.4 Million |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 1.45 Billion | 1.26 Billion |
Cash at beginning of period | - | - | - | - | 567.77 Million | 1 Billion |
Cash at end of period | - | - | - | - | 763.12 Million | 567.77 Million |
Capital Expenditure | - | - | - | - | -199.4 Million | -117.04 Million |
Effect of forex changes on cash | - | - | - | - | 50.85 Million | -15.23 Million |
Net cash flow / Change in cash | - | - | - | - | 195.35 Million | -436.14 Million |
Free Cash Flow | - | - | - | - | -574.7 Million | 799.65 Million |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 Q3 | 2018 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -67.9 Thousand | -99.7 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | - | 103.7 Thousand | 127.6 Thousand |
Investing Cash Flow | - | - | - | - | -258.6 Million | 12.2 Million |
Investments in PPE | - | - | - | - | 7.8 Million | -2.3 Million |
Acquisitions | - | - | - | - | -541.2 Million | 538.3 Million |
Investment purchases | - | - | - | - | 1.03 Billion | -2.7 Billion |
Sales/Maturities of investments | - | - | - | - | -108.2 Million | 1.6 Billion |
Other Investing Activities | - | - | - | - | -642.4 Million | 569.5 Million |
Financing Cash Flow | - | - | - | - | 8.2 Million | 60.3 Million |
Debt repayment | - | - | - | - | -7.6 Million | -2 Million |
Dividends payments | - | - | - | - | -16.6 Million | -49.9 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 32.4 Million | 112.2 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | 1.2 Billion | 1.13 Billion |
Cash at end of period | - | - | - | - | 993.9 Million | 1.2 Billion |
Capital Expenditure | - | - | - | - | 7.8 Million | -2.3 Million |
Effect of forex changes on cash | - | - | - | - | 7.5 Million | -36.4 Million |
Net cash flow / Change in cash | - | - | - | - | -207.1 Million | 64 Million |
Free Cash Flow | - | - | - | - | 43.6 Million | 25.6 Million |
3615
001780
BGTG
PME
3407
8068